Selected research
Industry Growth & Trends
Global Bordetella Vaccine for Dogs Industry Growth and Trends Forecast to 2032
Market perspective
The global Bordetella Vaccine for Dogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bordetella Vaccine for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bordetella Vaccine for Dogs include Elanco, Boehringer Ingelheim(Merial), Merck Animal Health and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bordetella Vaccine for Dogs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bordetella Vaccine for Dogs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bordetella Vaccine for Dogs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bordetella Vaccine for Dogs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Bordetella Vaccine for Dogs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bordetella Vaccine for Dogs Market by Company
Elanco
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Bordetella Vaccine for Dogs Segment by Type
Injectable Bordetella Vaccine
Oral Bordetella Vaccine
Intranasal Bordetella Vaccine
Bordetella Vaccine for Dogs Segment by Application
Puppies
Adult Dogs
Bordetella Vaccine for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bordetella Vaccine for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bordetella Vaccine for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bordetella Vaccine for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bordetella Vaccine for Dogs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Bordetella Vaccine for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable Bordetella Vaccine
- Oral Bordetella Vaccine
- Intranasal Bordetella Vaccine
Applications
- Puppies
- Adult Dogs
Companies covered
- Elanco
- Boehringer Ingelheim(Merial)
- Merck Animal Health
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bordetella Vaccine for Dogs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bordetella Vaccine for Dogs Sales Estimates and Forecasts (2021-2032)
- 1.3 Bordetella Vaccine for Dogs Market by Type
- 1.3.1 Injectable Bordetella Vaccine
- 1.3.2 Oral Bordetella Vaccine
- 1.3.3 Intranasal Bordetella Vaccine
- 1.4 Global Bordetella Vaccine for Dogs Market Size by Type
- 1.4.1 Global Bordetella Vaccine for Dogs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Bordetella Vaccine for Dogs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Bordetella Vaccine for Dogs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Bordetella Vaccine for Dogs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Bordetella Vaccine for Dogs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Bordetella Vaccine for Dogs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Bordetella Vaccine for Dogs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Bordetella Vaccine for Dogs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Bordetella Vaccine for Dogs Industry Trends
- 2.2 Bordetella Vaccine for Dogs Industry Drivers
- 2.3 Bordetella Vaccine for Dogs Industry Opportunities and Challenges
- 2.4 Bordetella Vaccine for Dogs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Bordetella Vaccine for Dogs Revenue (2021-2026)
- 3.2 Global Top Players by Bordetella Vaccine for Dogs Sales (2021-2026)
- 3.3 Global Top Players by Bordetella Vaccine for Dogs Price (2021-2026)
- 3.4 Global Bordetella Vaccine for Dogs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bordetella Vaccine for Dogs Major Company Production Sites & Headquarters
- 3.6 Global Bordetella Vaccine for Dogs Company, Product Type & Application
- 3.7 Global Bordetella Vaccine for Dogs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bordetella Vaccine for Dogs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bordetella Vaccine for Dogs Players Market Share by Revenue in 2025
- 3.8.3 2025 Bordetella Vaccine for Dogs Tier 1, Tier 2, and Tier 3
4 Bordetella Vaccine for Dogs Regional Status and Outlook
- 4.1 Global Bordetella Vaccine for Dogs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Bordetella Vaccine for Dogs Historic Market Size by Region
- 4.2.1 Global Bordetella Vaccine for Dogs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Bordetella Vaccine for Dogs Sales in Value by Region (2021-2026)
- 4.2.3 Global Bordetella Vaccine for Dogs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Bordetella Vaccine for Dogs Forecasted Market Size by Region
- 4.3.1 Global Bordetella Vaccine for Dogs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Bordetella Vaccine for Dogs Sales in Value by Region (2027-2032)
- 4.3.3 Global Bordetella Vaccine for Dogs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bordetella Vaccine for Dogs by Application
- 5.1 Bordetella Vaccine for Dogs Market by Application
- 5.1.1 Puppies
- 5.1.2 Adult Dogs
- 5.2 Global Bordetella Vaccine for Dogs Market Size by Application
- 5.2.1 Global Bordetella Vaccine for Dogs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Bordetella Vaccine for Dogs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Bordetella Vaccine for Dogs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Bordetella Vaccine for Dogs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Bordetella Vaccine for Dogs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Bordetella Vaccine for Dogs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Bordetella Vaccine for Dogs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Bordetella Vaccine for Dogs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Elanco
- 6.1.1 Elanco Company Information
- 6.1.2 Elanco Business Overview
- 6.1.3 Elanco Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Elanco Bordetella Vaccine for Dogs Product Portfolio
- 6.1.5 Elanco Recent Developments
- 6.2 Boehringer Ingelheim(Merial)
- 6.2.1 Boehringer Ingelheim(Merial) Company Information
- 6.2.2 Boehringer Ingelheim(Merial) Business Overview
- 6.2.3 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boehringer Ingelheim(Merial) Bordetella Vaccine for Dogs Product Portfolio
- 6.2.5 Boehringer Ingelheim(Merial) Recent Developments
- 6.3 Merck Animal Health
- 6.3.1 Merck Animal Health Company Information
- 6.3.2 Merck Animal Health Business Overview
- 6.3.3 Merck Animal Health Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Animal Health Bordetella Vaccine for Dogs Product Portfolio
- 6.3.5 Merck Animal Health Recent Developments
- 6.4 Zoetis
- 6.4.1 Zoetis Company Information
- 6.4.2 Zoetis Business Overview
- 6.4.3 Zoetis Bordetella Vaccine for Dogs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Zoetis Bordetella Vaccine for Dogs Product Portfolio
- 6.4.5 Zoetis Recent Developments
7 North America by Country
- 7.1 North America Bordetella Vaccine for Dogs Sales by Country
- 7.1.1 North America Bordetella Vaccine for Dogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Bordetella Vaccine for Dogs Sales by Country (2021-2026)
- 7.1.3 North America Bordetella Vaccine for Dogs Sales Forecast by Country (2027-2032)
- 7.2 North America Bordetella Vaccine for Dogs Market Size by Country
- 7.2.1 North America Bordetella Vaccine for Dogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Bordetella Vaccine for Dogs Market Size by Country (2021-2026)
- 7.2.3 North America Bordetella Vaccine for Dogs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Bordetella Vaccine for Dogs Sales by Country
- 8.1.1 Europe Bordetella Vaccine for Dogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Bordetella Vaccine for Dogs Sales by Country (2021-2026)
- 8.1.3 Europe Bordetella Vaccine for Dogs Sales Forecast by Country (2027-2032)
- 8.2 Europe Bordetella Vaccine for Dogs Market Size by Country
- 8.2.1 Europe Bordetella Vaccine for Dogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Bordetella Vaccine for Dogs Market Size by Country (2021-2026)
- 8.2.3 Europe Bordetella Vaccine for Dogs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Bordetella Vaccine for Dogs Sales by Country
- 9.1.1 Asia-Pacific Bordetella Vaccine for Dogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Bordetella Vaccine for Dogs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Bordetella Vaccine for Dogs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Bordetella Vaccine for Dogs Market Size by Country
- 9.2.1 Asia-Pacific Bordetella Vaccine for Dogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Bordetella Vaccine for Dogs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Bordetella Vaccine for Dogs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Bordetella Vaccine for Dogs Sales by Country
- 10.1.1 South America Bordetella Vaccine for Dogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Bordetella Vaccine for Dogs Sales by Country (2021-2026)
- 10.1.3 South America Bordetella Vaccine for Dogs Sales Forecast by Country (2027-2032)
- 10.2 South America Bordetella Vaccine for Dogs Market Size by Country
- 10.2.1 South America Bordetella Vaccine for Dogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Bordetella Vaccine for Dogs Market Size by Country (2021-2026)
- 10.2.3 South America Bordetella Vaccine for Dogs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Bordetella Vaccine for Dogs Sales by Country
- 11.1.1 Middle East and Africa Bordetella Vaccine for Dogs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Bordetella Vaccine for Dogs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Bordetella Vaccine for Dogs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Bordetella Vaccine for Dogs Market Size by Country
- 11.2.1 Middle East and Africa Bordetella Vaccine for Dogs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Bordetella Vaccine for Dogs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Bordetella Vaccine for Dogs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Bordetella Vaccine for Dogs Value Chain Analysis
- 12.1.1 Bordetella Vaccine for Dogs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Bordetella Vaccine for Dogs Production Mode & Process
- 12.2 Bordetella Vaccine for Dogs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Bordetella Vaccine for Dogs Distributors
- 12.2.3 Bordetella Vaccine for Dogs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst